CureVac AG

CureVac AG

CureVac AG

Overview
Date Founded

2000

Headquarters

Paul-Ehrlich-Strasse 15,Tuebingen, Baden Wuerttemberg 72076

Type of Company

Private

Employees (Worldwide)

251 - 500

Industries

Biotechnology
Pharmaceuticals

Company Description

CureVac AG engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.

Executives & Employees

Co-Founder, CPO

Chief Executive Officer

Chief Financial Officer

Chief Operating Officer

Chief Technology Officer (Chief Technology Officer)

Chief Scientific Officer (CSO)

Chief Medical Officer

Chief Business Officer (CBO) & Chief Commercial Officer (CCO)

Chief Scientific Officer

Director Communications

Board of Directors

Co-Founder & Managing Director at dievini Hopp BioTech holding GmbH & Co. KG

Managing Director at dievini Hopp BioTech holding GmbH & Co. KG

Director at CureVac AG

Co-Founder at Wipfler & Partner

Paths to CureVac AG
Potential Connections via
Relationship Science
You
CureVac AG
Advisors & Consultants
Publicist

Account Director at Brunswick Group LLP

Publicist

Vice President at Tiberend Strategic Advisors, Inc.

Clients

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma; teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease; and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel in 1999 and is headquartered in Copenhagen, Denmark.

Non-Profit Donations & Grants Received
Investors
Details Hidden

Qatar Holding LLC (QH) is a global investment house established in 2006, founded by the Qatar Investment Authority (QIA) and licensed by the Qatar Financial Centre Authority (QFCA). Qatar Holding LLC invests internationally and locally in strategic private and public equity as well as in other direct investments.Qatar Holding LLC strives to achieve steady long term returns on assets to benefit the State of Qatar and to diversify its economy.Qatar Holding LLC, a wholly-owned subsidiary of Qatar Investment Authority, is a world-class investment corporation and a preferred partner of choice for investors, financiers and other stakeholders. It is envisaged that the already significant investment portfolio of Qatar Holding will continue to grow. Key investments of Qatar Holding include Agricultural Bank of China, Barclays plc, Canary Wharf Group, Credit Suisse, Harrods Group, Hassad Food Company, J Sainsbury plc, London Stock Exchange, Lagardere, Porsche, Qatar Exchange, Qatar Telecom, Qatar National Bank, Banco Santander and Volkswagen AG.

Details Hidden

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Details Hidden

KfW Capital invest in German and European venture capital and venture debt funds.

Suppliers
Arcturus Therapeutics Holdings, Inc. Pharmaceuticals | San Diego, CA

Arcturus Therapeutics Holdings, Inc. is a clinical-stage mRNA medicines and vaccines company, which focuses on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by CureVac AG. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of CureVac AG's profile does not indicate a business or promotional relationship of any kind between RelSci and CureVac AG.